Performance of human papillomavirus (HPV) high risk (HR) DNA testing in daily clinical practice

被引：0
|
作者：
不详
机构：
来源：
CANCER CYTOPATHOLOGY | 2005年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：371 / 371
页数：1
相关论文
共 50 条
  • [1] Daily self-sampling for high-risk human papillomavirus (HR-HPV) testing
    Sanner, Karin
    Wikstrom, Ingrid
    Gustavsson, Inger
    Wilander, Erik
    Lindberg, Julia Hedlund
    Gyllensten, Ulf
    Olovsson, Matts
    JOURNAL OF CLINICAL VIROLOGY, 2015, 73 : 1 - 7
  • [2] ASC-US and high-risk HPV testing: Performance in daily clinical practice
    Selvaggi, Suzanne M.
    DIAGNOSTIC CYTOPATHOLOGY, 2006, 34 (11) : 731 - 733
  • [3] Identification of High-risk Human Papillomavirus (HR-HPV) in oropharyngeal cancer with a single test in routine clinical practice
    Casiraghi, O.
    Ben Lakhdar, A.
    Ma, X-J.
    Saulnier, P.
    Lacroix, L.
    Vielh, P.
    Mirghani, H.
    VIRCHOWS ARCHIV, 2015, 467 : S24 - S24
  • [4] Clinical Performance of the Cervista HPV Test in Detection of High Risk Human Papillomavirus
    Ji, H.
    Sako, J.
    Ewaskow, S. P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 899 - 900
  • [5] Comparison of the Abbott RealTime High Risk HPV with Genomica HPV Clinical Array for the detection of human papillomavirus DNA
    Sias, Catia
    Garbuglia, Anna Rosa
    Piselli, Pierluca
    Cimaglia, Claudia
    Lapa, Daniele
    Del Nonno, Franca
    Baiocchini, Andrea
    Capobianchi, Maria Rosaria
    APMIS, 2013, 121 (11) : 1054 - 1063
  • [6] New approach to human high-risk papillomavirus (HR-HPV) genotyping
    Weismanová, E
    Weismann, P
    Vizváryová, M
    Lehotská, V
    Krizanová, O
    Repiská, V
    Kausitz, J
    NEOPLASMA, 2002, 49 (04) : 217 - 224
  • [7] The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings
    Cardenas-Turanzas, Marylou
    Nogueras-Gonzalez, Graciela M.
    Scheurer, Michael E.
    Adler-Storthz, Karen
    Benedet, J. L.
    Beck, J. Robert
    Follen, Michele
    Cantor, Scott B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2865 - 2871
  • [8] Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV)
    Piyathilake, CJ
    Henao, OL
    Meleth, S
    Partridge, E
    Heimburger, D
    FASEB JOURNAL, 2003, 17 (04): : A373 - A373
  • [9] PREVALENCE OF HIGH RISK HUMAN PAPILLOMAVIRUS INFECTION AMONG IRANIAN WOMEN USING COBAS HPV DNA TESTING
    Farzaneh, F.
    Jamdar, F.
    Navidpour, F.
    Yunesi, S.
    Balvayeh, P.
    Hosseini, M.
    Ghodssi-Ghasemabadi, R. Robabeh
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A564 - A565
  • [10] Comparison of Human Papillomavirus (HPV) detection in urine and cervical samples using high-risk HPV DNA testing in Northern Thailand
    Khunamompong, S.
    Settakorn, J.
    Sukpan, K.
    Lekawanvijit, S.
    Siriaunkgul, S.
    VIRCHOWS ARCHIV, 2016, 469 : S281 - S282
12345